Why 2022 Is a Make-or-Break Year for Cannabis Stocks
By Billy Duberstein - Apr 1, 2022 at 10:10AM Key Points
The House will vote on the MORE Act for cannabis legalization today.
Even if it passes, it faces an uncertain vote in the Senate.
With high inflation and softening demand, U.S. cannabis stocks could have another lost year, and possibly longer, if Republicans do well in the midterm elections.
The House will vote on the MORE Act today. Without Congress' help, cannabis stocks will remain difficult investments in 2022 and beyond.
The U.S, House of Representatives is voting today on the Marijuana Opportunity Reinvestment and Expungement (MORE) Act, which will kick off a pivotal year for U.S. cannabis companies. Yet no matter what happens with today's vote, the fate of cannabis legalization -- and therefore cannabis stocks -- will likely fall to the Senate, where the path to passage is highly uncertain at best.
If you don't understand how pivotal these votes are to U.S. cannabis stocks, recent earnings results confirm they really, really need regulatory relief. Without it, cannabis stocks will be hard to own in 2022 versus other sectors.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.